Enzene Biosciences, a renowned biotechnology company, has successfully raised $50 million to bolster its operations across India and the US. This financial boost will be instrumental in expanding the company’s reach and facilitating its growth trajectory in these significant markets. Enzene’s Expansion Plan The funds raised will be strategically invested in expanding the company’s operations,…
In a significant development, Amgen, the multinational biopharmaceutical company, has found itself in the crosshairs of an antitrust lawsuit. The unexpected action has sent ripples through the pharmaceutical industry, leading to wider apprehensions about potential deals and mergers. The FTC’s Unexpected Move The U.S. Federal Trade Commission (FTC), in an unexpected turn of events, filed…
In a significant business move, MO Alternates, a prominent investment firm, has injected Rs 400 crore into Pan Health, a hygiene products manufacturer based in Rajkot. Pan Health is known for its widespread presence in the hygiene market, offering a range of products that cater to babies, adults, and women. Little Angel: Leading the Baby…
Pharmaceutical industry giant, Catalent, has recently announced a significant cut in its annual forecast, primarily due to a series of operational challenges. The company, which is a renowned global provider of advanced delivery technologies and development solutions for drugs, biologics, gene therapies, and consumer health products, has downgraded its predicted adjusted net income for the…
In an era where technology and healthcare continue to intersect, a rising star has emerged in the form of Virohan, a healthcare EdTech startup. The company recently announced that it has successfully raised a hefty sum of USD 7 million in funding. The round of funding was led by the renowned venture capital firm, Blume…
Haleon, the global leader in standalone consumer health business, has recently made a bold prediction about its financial prospects for the year 2023. The company, known for its extensive portfolio of non-prescription drugs, vitamins, and oral care products, anticipates organic revenue growth at the upper-end of its projections. Anticipated Revenue Growth Despite operating in a…
Johnson & Johnson’s consumer health unit, Kenvue, has recently made headlines by filing for its Initial Public Offering (IPO) ahead of a planned spin-off. This pivotal move marks an exciting chapter in the company’s story, setting the stage for what could be a significant shift in the pharmaceutical industry. The Kenvue Business Profile Kenvue, the…
